---
document_datetime: 2024-02-15 12:30:33
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/mevlyq-epar-all-authorised-presentations_en.pdf
document_name: mevlyq-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.3511517
conversion_datetime: 2025-12-14 21:55:52.53093
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Content (concentration) Pack size

EU/1/23/1789/001 Mevlyq 0.44 mg/ml Solution for injection Intravenous use vial (glass) 2 ml 1 vial